Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer
- PMID: 24768995
- DOI: 10.1016/j.febslet.2014.04.020
Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer
Abstract
Our recent study of the microRNA expression signature of prostate cancer (PCa) revealed that microRNA-224 (miR-224) is significantly downregulated in PCa tissues. Here, we found that restoration of miR-224 significantly inhibits PCa cell migration and invasion. Additionally, we found that oncogenic TPD52 is a direct target of miR-224 regulation. Silencing of the TPD52 gene significantly inhibits cancer cell migration and invasion. Moreover, TPD52 expression is upregulated in cancer tissues and negatively correlates with miR-224 expression. We conclude that loss of tumour-suppressive miR-224 enhances cancer cell migration and invasion in PCa through direct regulation of oncogenic TPD52.
Keywords: Prostate cancer; TPD52; Tumour suppressor; miR-224; microRNA.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.Tumour Biol. 2016 Jun;37(6):7481-91. doi: 10.1007/s13277-015-4623-4. Epub 2015 Dec 17. Tumour Biol. 2016. PMID: 26678891
-
Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.Int J Oncol. 2016 Nov;49(5):1870-1880. doi: 10.3892/ijo.2016.3690. Epub 2016 Sep 13. Int J Oncol. 2016. PMID: 27633630 Free PMC article.
-
microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.Biochem Biophys Res Commun. 2015 Jan 16;456(3):804-9. doi: 10.1016/j.bbrc.2014.12.026. Epub 2014 Dec 13. Biochem Biophys Res Commun. 2015. PMID: 25511701
-
Functional significance of aberrantly expressed microRNAs in prostate cancer.Int J Urol. 2015 Mar;22(3):242-52. doi: 10.1111/iju.12700. Epub 2015 Jan 20. Int J Urol. 2015. PMID: 25599923 Review.
-
miR-21, An Oncogenic Target miRNA for Cancer Therapy: Molecular Mechanisms and Recent Advancements in Chemo and Radio-resistance.Curr Gene Ther. 2017;16(6):375-389. doi: 10.2174/1566523217666170102105119. Curr Gene Ther. 2017. PMID: 28042781 Review.
Cited by
-
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4288-97. doi: 10.1073/pnas.1502068112. Epub 2015 Jul 17. Proc Natl Acad Sci U S A. 2015. PMID: 26187928 Free PMC article.
-
MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells.Mol Biotechnol. 2022 Sep;64(9):1003-1012. doi: 10.1007/s12033-022-00475-3. Epub 2022 Mar 23. Mol Biotechnol. 2022. PMID: 35320453
-
LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.J Exp Clin Cancer Res. 2018 Mar 12;37(1):56. doi: 10.1186/s13046-018-0724-4. J Exp Clin Cancer Res. 2018. PMID: 29530057 Free PMC article.
-
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.Oncotarget. 2015 Sep 8;6(26):21802-15. doi: 10.18632/oncotarget.5224. Oncotarget. 2015. PMID: 26307684 Free PMC article.
-
Tribbles-1 Expression and Its Function to Control Inflammatory Cytokines, Including Interleukin-8 Levels are Regulated by miRNAs in Macrophages and Prostate Cancer Cells.Front Immunol. 2020 Nov 27;11:574046. doi: 10.3389/fimmu.2020.574046. eCollection 2020. Front Immunol. 2020. PMID: 33329538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical